HologicFRA:HO1 57 Net Margin % is 17.09% as of Dec. 2025, which is 2% above its 10-year median of 16.70. GuruFocus rates FRA:HO1 with a GF Score™ of 57/100 and a GF Value™ of €70.17. The stock has 4 warning signs investors should review. Among 817 Medical Devices & Instruments companies, Hologic ranks better than 79.56% on this metric.
Net margin is calculated as Net Income divided by its Revenue. Hologic's Net Income for the
three
months ended in Dec. 2025 was €153 Mil. Hologic's Revenue for the
three
months ended in Dec. 2025 was €895 Mil. Therefore, Hologic's net margin for the quarter that ended in Dec. 2025 was 17.09%.
The historical rank and industry rank for Hologic's Net Margin % or its related term are showing as below:
FRA:HO1'
s Net Margin % Range Over the Past 10 Years
Min: -6.05 Med: 16.7 Max: 33.23
Current: 13.18
FRA:HO1's Net Margin % is ranked better than 79.56% of 817
companies
in the Medical Devices & Instruments industry
Industry Median: 2.09
vs FRA:HO1: 13.18
Hologic (FRA:HO1) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Hologic Net Margin % Related Terms
Hologic Net Margin % Historical Data
* Premium members only.
The historical data trend for Hologic's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:HO1 vs WST, COO, ALGN: Net Margin % Comparison
For the Medical Instruments & Supplies subindustry, Hologic's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hologic Net Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Hologic's Net Margin % distribution charts can be found below:
* The bar in red indicates where Hologic's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hologic (FRA:HO1) has a Net Margin % of 17.09% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on Hologic and its competitors. This is near median its historical median of 16.70. According to the industry distribution chart, Hologic ranks #167 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 20.4%.
Is Hologic's Net Margin % too high?
Hologic's current Net Margin % of 17.09% is near median its 10-year median of 16.70. The Medical Devices & Instruments industry median Net Margin % is 2.09. Hologic's value of 17.09% is 717.7% above this industry median. Based on the distribution chart, Hologic ranks #167 out of 817 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Hologic has a GF Score™ of 57/100, reflecting its overall financial health beyond just this single metric.
How does Hologic's Net Margin % compare to WST and COO?
According to the Medical Devices & Instruments industry distribution chart, Hologic ranks #167 out of 817 companies for Net Margin %. This places Hologic in the top 20% of its industry — outperforming the majority of peers. The industry median Net Margin % is 2.09. Hologic's value of 17.09% is 717.7% above this benchmark. While the company's 10-year median is 16.70 vs. the industry median of 2.09, Hologic has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.09, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hologic's current Net Margin % of 17.09% is 717.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Hologic and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hologic's current Net Margin % is 17.09%, which is near median its own 10-year median of 16.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hologic stock overvalued right now?
Hologic (FRA:HO1) has a current Net Margin % of 17.09%. The stock's GF Value™ is €70.17, compared to a current price of €65.00 — trading 7.4% below its estimated fair value. The current Net Margin % is 17.09%, which is near median its 10-year median of 16.70 and 717.7% above the Medical Devices & Instruments industry median of 2.09. Hologic's overall GF Score™ is 57/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Hologic (FRA:HO1), the current Net Margin % is 17.09% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hologic (FRA:HO1) Overvalued in 2026?
Based on GuruFocus' analysis, Hologic stock appears to be undervalued.
The current stock price of €65.00 is trading 7.4% below its estimated GF Value™ of €70.17.
Key valuation signals for FRA:HO1:
Net Margin %: 17.09% (near median its 10-year median of 16.70)
GF Value™: €70.17 vs. price of €65.00 (7.4% below fair value)
Industry Position: 717.7% above the Medical Devices & Instruments median (#167 of 817)
No single metric tells the full story. See the FRA:HO1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
57GF Score
Get the complete analysis for FRA:HO1
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:HO1 has been successfully added to your 
